IP Library Granted Patent US 8,227,514
Granted Patent B2
US 8,227,514 · App. 12/710,382 · Granted Jul 24, 2012

Topical application of travoprost for combating hair loss

Assignee: Galderma Research & Development
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,227,514
App. No.
12/710,382
Granted
Jul 24, 2012
Kind
B2
Abstract

Travoprost medicament compositions for non-daily topical application are useful for simulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of human hair shafts/follicles, e.g., for the treatment of androgenic alopecia, such medicament compositions being at least twice applied over a time interval of greater than 24 hours.

Claims (10)

1. A non-daily method for stimulating or inducing the growth and/or decreasing the loss and/or increasing the density and/or reducing the heterogeneity in the diameter of hair follicles in a human subject, comprising topically applying a thus effective amount of a medicament composition which comprises from 0.005 to 0.01% travoprost onto such hair follicles, for such non-daily period of time as required to elicit the desired effect, wherein at least two non-daily topical applications are carried out at a time interval between them of every two, three, four, five or six days, or weekly, or once, twice or three times monthly wherein the travoprost is the only prostaglandin hair growth active agent in the medicament composition.

2. The non-daily method as defined by claim 1 , comprising such topical application every four, five or six days.

3. The non-daily method as defined by claim 1 , comprising a weekly topical application.

4. The non-daily method as defined by claim 1 , comprising a monthly topical application.

5. The non-daily method as defined by claim 1 , comprising a twice or thrice monthly topical application.

6. The non-daily method as defined by claim 1 , in which said medicament comprises a lotion, a cream, an emulsion, a salve, a mascara, a powder, a shampoo or a conditioner.

7. The non-daily method as defined by claim 1 , said hair follicles comprising head hairs, body hairs and/or eyelashes.

8. The non-daily method as defined by claim 1 , wherein said subject is in need of treatment of androgenic alopecia.

9. The non-daily method as defined by claim 8 , in which said medicament composition is topically applied every four, five or six days, or weekly, or once, twice or three times monthly.

10. A non-daily method for the treatment of androgenic alopecia, comprising topically applying a thus effective amount of a medicament composition which comprises from 0.005 to 0.01% travoprost onto the scalp of an individual in need of such treatment, for such non-daily period of time as required to elicit the desired effect, wherein at least two non-daily topical applications are carried out at a time interval between them of every two, three, four, five or six days, or weekly, or once, twice or three times monthly wherein the travoprost is the only prostaglandin hair growth active agent in the medicament composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2010
From: RETHORE, SANDRINE; ROSIGNOLI, CARINE; JOMARD, ANDRE; VOEGEL, JOHANNES
To: GALDERMA RESEARCH & DEVELOPMENT
Reel/Frame 024197/0580 →
Priority Claims (1)
FR 07 57208 · Aug 28, 2007 · national
Continuity (2)
Continuation PCTFR2008051539 · Aug 28, 2008
Related Publication 20100190853A1 · Jul 29, 2010